Less than half of patients with MS continually adhere to drug therapies for treatment, Canadian study finds

Disease-modifying drugs (DMDs) are injected medications used to slow the progression of multiple sclerosis, and have been shown to reduce the frequency and severity of relapses. But according to a new Canadian study, adherence to all DMDs is low, with less than half of patients, or 44 per cent, continually adherent after two years.

Read the whole article on Science Daily

More from Science Daily